Involvement of the antioxidant effect and anti-inflammatory response in butyrate-inhibited vascular smooth muscle cell proliferation

Pharmaceuticals

Volumn 7, Issue 11, 2014, Pages 1008-1027

  Mathew, Omana P ^a   Ranganna, Kasturi ^a   Milton, Shirlette G ^a  

^a TEXAS SOUTHERN UNIVERSITY   (United States)

Author keywords

Butyrate; Glutathione peroxidase; Inflammation; NF B; Proliferation; Vascular smooth muscle cells

Indexed keywords

BUTYRIC ACID; CYCLOOXYGENASE 2; GLUTATHIONE PEROXIDASE 3; I KAPPA B ALPHA; I KAPPA B BETA; INDUCIBLE NITRIC OXIDE SYNTHASE; PHOSPHOLIPID HYDROPEROXIDE GLUTATHIONE PEROXIDASE; TRANSCRIPTION FACTOR RELA; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CATALYSIS; CELL CYCLE ARREST; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG TARGETING; ENZYME REGULATION; GENE EXPRESSION REGULATION; NONHUMAN; PROTEIN PHOSPHORYLATION; RAT; UPREGULATION; VASCULAR SMOOTH MUSCLE;

EID: 84910037370     PISSN: None     EISSN: 14248247     Source Type: Journal    
DOI: 10.3390/ph7111008     Document Type: Article

References (58)

1. Dzau, V.J.; Braun-Dullaeus, R.C.; Sedding, D.G. Vascular proliferation and atherosclerosis: New perspectives and therapeutic strategies. Nat. Med. 2002, 8, 1249-1256.
2. Holmes, D.R., Jr. State of the art in coronary intervention. Am. J. Cardiol. 2003, 91, 50A-53A.
3. Melo, L.G.; Gnecchi, M.; Pachori, A.S.; Wang, K.; Dzau, V.J. Gene- and cell-based therapies for cardiovascular diseases: Current status and future directions. Eur. Heart. J. Suppl. 2004, 6, E24-E35.
4. Ranganna, K.; Yatsu, F.M.; Mathew, O.P. Insights into the pathogenesis and intervention of atherosclerosis. Vasc. Dis. Prev. 2006, 3, 375-390.
5. Ranganna, K.; Yatsu, F.M.; Hayes, B.E. Butyrate, a small pleiotropic molecule with multiple cellular and molecular actions: Its role as an anti-atherogenic agent. Recent Res. Dev. Mol. Cell. Biochem. 2005, 2, 123-151.
6. Ekström, T.J. Epigenetic control of gene expression. Biochim. Biophys. Acta 2009, 1790, 845-846.
7. Pons, D.; de Vries, F.R.; van den Elsen, P.J.; Heijmans, B.T.; Quax, P.H.; Jukema, J.W. Epigenetic histone acetylation modifiers in vascular remodeling: New targets for therapy in cardiovascular disease. Eur. Heart J. 2009, 30, 266-277.
8. Turunen, M.P.; Aavik, E.; Yla-Herttuala, S. Epigenetics and atherosclerosis. Biochim. Biophys. Acta 2009, 1790, 886-891.
9. Ranganna, K.; Yatsu, F.M.; Mathew, O.P. Emerging Epigenetic Therapy for Vascular Proliferative Diseases. Atherogenesis; Parthasarathy, S., Ed.; InTech: Rijeka, Croatia, 2011.
10. Mathew, O.P.; Ranganna, K.; Yatsu, F.M. Butyrate, an HDAC inhibitor, stimulates interplay between different posttranslational modifications of histone H3 and differently alters G1- specific cell cycle proteins in vascular smooth muscle cells. Biomed. Pharmacother. 2010, 64, 733-740.
11. Findeisen, H.M.; Gizard, F.; Zhao, Y.; Qing, H.; Heywood, E.B.; Jones, K.L.; Cohn, D.; Bruemmer, D. Epigenetic regulation of vascular smooth muscle cell proliferation and neointima formation by histone deacetylase inhibition. Arterioscler Thromb. Vasc. Biol. 2011, 31, 851-860.
12. Ranganna, K.; Mathew, O.P.; Yatsu, F.M.; Yousefipour, Z.; Hayes, B.E.; Milton, S.G. Involvement of glutathione/glutathione S-transferase antioxidant system in butyrate-inhibited vascular smooth muscle cell proliferation. FEBS J. 2007, 274, 5962-5978.
13. Ranganna, K.; Yousefipour, Z.; Yatsu, F.M.; Milton, S.G.; Hayes, B.E. Gene expression profile of butyrate-inhibited vascular smooth muscle cell proliferation. Mol. Cell. Biochem. 2003, 254, 21-36.
14. Burk, R.F. Protection against free radical injury by selenoenzymes. Pharmacol. Ther. 1990, 45, 383-385.
15. Arthur, J.R. The glutathione peroxidases. Cell. Mol. Life. Sci. 2000, 57, 1825-1835.
16. Brigelius-Flohé, R. Glutathione peroxidases and redox-regulated transcription factors. Biol. Chem. 2006, 387, 1329-1335.
17. Brigelius-Flohe, R.; Maiorino, M. Glutathione peroxidases. Biochim Biophys Acta. 2013, 1830, 3289-3303.
18. Rueckschloss, U.; Duerrschmidt, N.; Morawietz, H. NADPH oxidase in endothelial cells: Impact on atherosclerosis. Antioxid Redox Signal. 2003, 5, 171-180.
19. Finkel, T. Oxidant signals and oxidative stress. Curr. Opin. Cell Biol. 2003, 15, 247-254.
20. 2 for platelet-derived growth factor signal transduction. Science 1995, 270, 296-299.
21. Wheeler, M.L.; Defranco, A.L. Prolonged production of reactive oxygen species in response to B cell receptor stimulation promotes B cell activation and proliferation. J Immunol. 2012, 189, 4405-4416.
22. Zhang, Y.; Handy, D.E.; Loscalzo, J. Adenosine-dependent induction of glutathione peroxidase 1 in human primary endothelial cells and protection against oxidative stress. Circ. Res. 2005, 96, 831-837.
23. Weiss, N.; Zhang, Y.Y.; Heydrick, S.; Bierl, C.; Loscalzo, J. Overexpression of cellular glutathione peroxidase rescues homocyst(e)ine-induced endothelial dysfunction. Proc. Natl. Acad. Sci. USA 2001, 98, 12503-12508.
24. Hoehn, B.; Yenari, M.A.; Sapolsky, R.M.; Steinberg, G.K. Glutathione peroxidase overexpression inhibits cytochrome C release and proapoptotic mediators to protect neurons from experimental stroke. Stroke 2003, 34, 2489-2494.
25. Shiomi, T.; Tsutsui, H.; Matsusaka, H.; Murakami, K.; Hayashidani, S.; Ikeuchi, M.; Wen, J.; Kubota, T.; Utsumi, H.; Takeshita, A. Overexpression of glutathione peroxidase prevents left ventricular remodeling and failure after myocardial infarction in mice. Circulation. 2004, 109, 544-549.
26. Ran, Q.; Gu, M.; Van Remmen, H.; Strong, R.; Roberts, J.L.; Richardson, A. Glutathione peroxidase 4 protects cortical neurons from oxidative injury and amyloid toxicity. J. Neurosci. Res. 2006, 84, 202-208.
27. Wenk, J.; Schüller, J.; Hinrichs, C.; Syrovets, T.; Azoitei, N.; Podda, M.; Wlaschek, M.; Brenneisen, P.; Schneider, L.A.; Sabiwalsky, A.; et al. Overexpression of phospholipid-hydroperoxide glutathione peroxidase in human dermal fibroblasts abrogates UVA irradiation-induced expression of interstitial collagenase/matrix metalloproteinase-1 by suppression of phosphatidylcholine hydroperoxide-mediated NFkappaB activation and interleukin-6 release. J. Biol. Chem. 2004, 279, 45634-45642.
28. Crack, P.J.; Taylor, J.M.; Ali, U.; Mansell, A.; Hertzog, P.J. Potential contribution of NF-kappaB in neuronal cell death in the glutathione peroxidase-1 knockout mouse in response to ischemiareperfusion injury. Stroke 2006, 37, 1533-1538.
29. Hayden, M.S.; Ghosh, S. Shared principles in NF-kappaB signaling. Cell 2008, 132, 344-362.
30. Hayden, M.S.; West, A.P.; Ghosh, S. NF-kappaB and the immune response. Oncogene 2006, 25, 6758-6580.
31. Gilmore, T.D. Introduction to NF-kappaB: players, pathways, perspectives. Oncogene 2006, 25, 6680-6684.
32. Banning, A.; Schnurr, K.; Böl, G.F.; Kupper, D.; Müller-Schmehl, K.; Viita, H.; Ylä- Herttuala, S.; Brigelius-Flohé, R. Inhibition of basal and interleukin-1-induced VCAM-1 expression by phospholipid hydroperoxide glutathione peroxidase and 15-lipoxygenase in rabbit aortic smooth muscle cells. Free Radic. Biol. Med. 2004, 36, 135-144.
33. Brigelius-Flohé, R.; Friedrichs, B.; Maurer, S.; Schultz, M.; Streicher, R. Interleukin-1-induced nuclear factor kB activation is inhibited by overexpression of phospholipid hydroperoxide glutathione peroxidase in a human endothelial cell line. Biochem. J. 1997, 328, 199-203.
34. Lührs, H.; Gerke, T.; Müller, J.G.; Melcher, R.; Schauber, J.; Boxberge, F.; Scheppach, W.; Menzel, T. Butyrate inhibits NF-kappaB activation in lamina propria macrophages of patients with ulcerative colitis. Scand. J. Gastroenterol. 2002, 37, 458-466.
35. Segain, J.P.; Raingeard de la Blétière, D.; Bourreille, A.; Leray, V.; Gervois, N.; Rosales, C.; Ferrier, L.; Bonnet, C.; Blottière, H.M.; Galmiche, J.P. Butyrate inhibits inflammatory responses through NFkappaB inhibition: implications for Crohn's disease. Gut 2000, 47, 397-403.
36. Milton, S.G.; Mathew, O.P.; Yatsu, F.M.; Ranganna, K. Differential cellular and molecular effects of butyrate and trichostatin A on vascular smooth muscle cells. Pharmaceuticals 2012, 5, 925-943.
37. Chabory, E.; Damon, C.; Lenoir, A.; Henry-Berger, J.; Vernet, P.; Cadet, R.; Saez, F.; Drevet, J.R. Mammalian glutathione peroxidases control acquisition and maintenance of spermatozoa integrity. J. Anim. Sci. 2010, 88, 1321-1331.
38. Miranda, S.G.; Wang, Y.J.; Purdie, N.G.; Osborne, V.R.; Coomber, B.L.; Cant, J.P. Senenomethionine stimulates expression of glutathione peroxidase 1 and 3 and growth of bovine mammary epithelial cell in primary culture. J. Diary Sci. 2009, 92, 2670-2683.
39. Kang, D.H.; Kang, S.W. Targeting cellular antioxidant enzymes for targeting atherosclerotin vascular disease. Biomol. Ther. 2013, 21, 89-96.
40. Buijsse, B.; Lee, D-H.; Steffen, L.; Erickson, R.R.; Luepker, R.V.; Jacobs, D.R., Jr.; Holtzman, J.L. Low serum dlutathione peroxidase activity is associated with cardiovascular mortality in individuals with low HDLc's. PloS ONE 2012, 7, e38901.
41. Voetsch, B.R.; Jin, C . ; Bierl, C . ; Benke, K . S. ; Kenet, G . ; Simioni, P.; Ottaviano, F.; Damasceno, B.P.; Annichino-Bizacchi, J.M.; Handy, D.E.; Loscalzo, J. Promoter polymorphisms in the plasma glutathione peroxidase (GPx-3) gene: a novel risk factor for arterial ischemic stroke among young adults and children. Stroke 2007, 38, 41-49.
42. Savaskan, N.E.; Ufer, C.; Kühn, H.; Borchert, A. Molecular biology of glutathione peroxidase 4: from genomic structure to developmental expression and neural function. Biol. Chem. 2007, 388, 1007-1017.
43. Guo, Z.; Ran, Q.; Roberts, L.J., 2nd.; Zhou, L.; Richardson, A.; Sharan, C.; Wu, D.; Yang, H. Suppression of atherogenesis by overexpression of glutathione peroxidase-4 in apolipoprotein E-deficient mice. Free Radic. Biol. Med. 2008, 44, 343-352.
44. Borchert, A.; Wang, C.C.; Ufer, C.; Schiebel, H.; Savaskan, N.E.; Kuhn, H. The role of phospholipid hydroperoxide glutathione peroxidase isoforms in murine embryogenesis. J. Biol. Chem. 2006, 28, 19655-19664.
45. Witztum, J.L.; Steinberg, D. The oxidative modification hypothesis of atherosclerosis: Does it hold for humans? Trends Cardiovasc. Med. 2001, 11, 93-102.
46. Raines, E.W.; Ross, R. Smooth muscle cells and the pathogenesis of the lesions of atherosclerosis. Br. Heart J. 1993, 69, S30-S37.
47. Brigelius-Flohé, R.; Maurer, S.; Lötzer, K.; Böl, G.; Kallionpää, H.; Lehtolainen, P.; Viita, H.; Ylä-Herttuala, S. Overexpression of PHGPx inhibits hydroperoxide-induced oxidation, NFkappaB activation and apoptosis and affects oxLDL-mediated proliferation of rabbit aortic smooth muscle cells. Atherosclerosis 2000, 152, 307-316.
48. Ran, Q.; Liang, H.; Gu, M.; Qi, W.; Walter, C.A.; Roberts, L.J., 2nd.; Herman, B.; Richardson, A.; Van Remmen, H. Transgenic mice overexpressing glutathione peroxidase 4 are protected against oxidative stress-induced apoptosis. J. Biol. Chem. 2004, 279, 55137-55146.
49. Hayden, M.S.; Ghosh, S. NF-κB, the first quarter-century: Remarkable progress and outstanding questions. Genes Dev. 2012, 26, 203-234.
50. Yang, F.; Tang, E.; Guan, K.; Wang, C.Y. IKK beta plays an essential role in the phosphorylation of RelA/p65 on serine 536 induced by lipopolysaccharide. J. Immunol. 2003, 170, 5630-5635.
51. Häcker, H.; Karin, M. Regulation and function of IKK and IKK-related kinases. Sci. STKE 2006, 2006, re13.
52. Chen, L.F.; Williams, S.A.; Mu, Y.; Nakano, H.; Duerr, J.M.; Buckbinder, L.; Greene, W.C. NF-κB RelA phosphorylation regulates RelA acetylation. Mol. Cell Biol. 2005 25, 7966-7975.
53. Perkins, N.D. Post-translational modifications regulating the activity and function of the nuclear factor kappa B pathway. Oncogene. 2006, 25, 6717-6730.
54. Wang, S.; Melnyk, J.; Tsao, R.; Marcone, M.F. How natural dietary antioxidants in fruits, vegetables and legumes promote vascular health. Food Res. Intl. 2011, 44, 14-22.
55. Kim, J.Y.; Park, H.J.; Um, S.H.; Sohn, E.H.; Kim, B.O.; Moon, E.Y.; Rhee, D.K.; Pyo, S. ulforaphane suppresses vascular adhesion molecule-1 expression in TNF-α-stimulated mouse vascular smooth muscle cells: involvement of the MAPK, NF-κB and AP-1 signaling pathways. Vascul. Pharmacol. 2012, 56, 131-141.
56. Aggarwal, B.B.; Van Kuiken, M.E.; Iyer, L.H.; Harikumar, K.B.; Sung, B. Molecular targets of nutraceuticals derived from dietary spices: potential role in suppression of inflammation and tumorigenesis. Exp. Biol. Med. 2009, 234, 825-849.
57. Vinolo, M.A.; Rodrigues, H.G.; Nachbar, R.T.; Curi, R. Regulation of inflammation by short chain fatty acids. Nutrients 2011, 3, 858-876.
58. Russo, I.; Luciani, A.; De Cicco, P.; Troncone, E.; Ciacci, C. Butyrate attenuates lipopolysaccharide-induced inflammation in intestinal cells and Crohn's mucosa through modulation of antioxidant defense machinery. PLoS One 2012, 7, e32841.